(19)
(11) EP 4 816 370 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24827539.8

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61K 31/519(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/04; A61P 35/00; C07B 2200/13
(86) International application number:
PCT/US2024/057668
(87) International publication number:
WO 2025/117680 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605265 P

(71) Applicant: Flagship Pioneering Innovations VII, LLC
Cambridge, MA 02142 (US)

(72) Inventors:
  • TIJANI, Rasheed O.
    Cambridge, Massachusetts 02142 (US)
  • KUNAPARAJU, Vijay
    Cambridge, Massachusetts 02142 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) FORMS OF 3-(2-HYDROXY-2-METHYLPROPYL)-8-(PYRIDIN-3-YL)-6-(6-(TRIFLUOROMETHYL)PYRIDIN-3-YL)PYRIDO[3,4-D]PYRIMIDIN-4(3H)-ONE